Titan Pharmaceuticals, Inc. TTNP
Set alert
2.34 0.00 0.00%
As of Dec 16, 1:46 PM ET
2.30 Day range 2.69
3.14 52-week range 14.80
- YTD
- -28.22%
- 1 year
- -55.09%
- Open
- 2.55
- Prev close
- 2.34
- Mkt cap
- 2.96M
- Vol
- 131.90K
- Avg vol
- 18.01K
- EPS
- -6.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.30
- High
- 2.69
- Forward P/E
- -3.56
- Beta
- 1.13
- Short ratio
- 0.66
- Inst. own
- 1.85%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 24, 2024
- 50-d avg
- 3.97
- 200-d avg
- 5.73
- 1y target
- 0.00
6M chart
Signals (58)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Sep 30, 2025 | 1 year ago |
| SMA: Bullish | Sep 30, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 30, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 25, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 24, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 23, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 19, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 18, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 16, 2025 | 1 year ago |
| SMA: Bearish | Sep 11, 2025 | 1 year ago |
| SMA: Bearish | Sep 11, 2025 | 1 year ago |
| SMA: Bullish | Sep 10, 2025 | 1 year ago |
| SMA: Bullish | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Aug 28, 2025 | 1 year ago |
| SMA: Bearish | Aug 28, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 28, 2025 | 1 year ago |
| SMA: Bullish | Aug 12, 2025 | 1 year ago |
| SMA: Bullish | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 12, 2025 | 1 year ago |
| SMA: Bearish | Jul 29, 2025 | 1 year ago |
| SMA: Bullish | Jul 28, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 25, 2025 | 1 year ago |
| SMA: Bearish | Jul 25, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 17, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jul 9, 2025 | 1 year ago |
| SMA: Bearish | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 20, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 6, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 5, 2025 | 1 year ago |
| MACD: Sell Signal | May 20, 2025 | 1 year ago |
| RSI: Overbought | May 8, 2025 | 1 year ago |
| MACD: Buy Signal | May 1, 2025 | 1 year ago |
| SMA: Bullish | Apr 30, 2025 | 1 year ago |
| SMA: Bearish | Apr 29, 2025 | 1 year ago |
| SMA: Bearish | Apr 29, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 29, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 28, 2025 | 1 year ago |
| SMA: Bearish | Apr 25, 2025 | 1 year ago |
| SMA: Bullish | Apr 24, 2025 | 1 year ago |
| SMA: Bullish | Apr 22, 2025 | 1 year ago |
| SMA: Bearish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Apr 17, 2025 | 1 year ago |
| SMA: Bullish | Apr 16, 2025 | 1 year ago |
| SMA: Bearish | Apr 15, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Apr 11, 2025 | 1 year ago |
| SMA: Bullish | Apr 10, 2025 | 1 year ago |
| SMA: Bullish | Apr 8, 2025 | 1 year ago |
| SMA: Bearish | Apr 7, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Apr 4, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 2, 2025 | 1 year ago |
Key statistics
- Market cap
- 2.96M
- Enterprise value
- -1.00M
- Trailing P/E
- 0.00
- Forward P/E
- -3.56
- PEG ratio
- 0.00
- Price / sales
- 987.37
- Price / book
- 0.74
- EPS (TTM)
- -6.64
- Beta
- 1.13
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 3.00K
- Revenue growth
- 0.00%
- Free cash flow
- -5.21M
- Total cash
- 4.09M
- Total debt
- 0
- Return on equity
- -368.99%
- Shares outstanding
- 914.23K
- Short % of float
- 1.23%
- 50-day average
- 3.97
- 200-day average
- 5.73
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Dec 24, 2024
Expected Dec 24, 2024. Consensus EPS estimate 0.00.
Financials — quick view
TTNP Revenue — quarterly 0
TTNP Net income — quarterly -689.00K
TTNP EPS — quarterly -0.65
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 24, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Aug 15, 2024 | Jun 1, 2024 | 0.00 | -2.29 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -1.24 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -0.40 | — | — |
| Nov 14, 2022 | Sep 1, 2022 | 0.00 | — | — | — |
About Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder. The company was founded in 1991 and is based in South San Francisco, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- titanpharm.com
News
- Titan Pharmaceuticals, Inc. Announces Closing of Merger with Black Titan Corporation
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP
- URGENT: The M&A Class Action Firm Encourages $hareholders to Act Before Vote – Titan Pharmaceuticals, Inc. (Nasdaq: TTNP)
- 12 Health Care Stocks Moving In Friday's Intraday Session
Your note
Sign in to keep a note on TTNP — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEN-TZVI AVRAHAM | Director | Stock Award(Grant) | Oct 24, 2023 | 66,250 |
| CHASEY PETER LOUIS | Director | Stock Award(Grant) | Jul 25, 2023 | 50,000 |
| CHOONG CHOON HAU | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Mar 17, 2024 | 3,802,100 |
| GREENBERG ERIC HOWARD | Director | Stock Award(Grant) | Oct 24, 2023 | 66,250 |
| LAZAR DAVID ELLIOT | Chief Executive Officer | Stock Award(Grant) | Jul 25, 2023 | 100,000 |
| MCMURDO MATTHEW CHARLES | Director | Stock Award(Grant) | Oct 24, 2023 | 66,250 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 1.21% | 11,066 | 35.85K | Sep 29, 2024 |
| UBS Group AG | 0.52% | 4,773 | 15.46K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.08% | 743 | 2.41K | Sep 29, 2024 |
| MCF Advisors LLC | 0.02% | 165 | 534 | Sep 29, 2024 |
| Global Wealth Strategies & Associates | 0.00% | 2 | 6 | Sep 29, 2024 |
| Osaic Holdings Inc | 0.00% | 10 | 32 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.45% | 4,103 | 13.29K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.34% | 3,146 | 10.19K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.11% | 963 | 3.12K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.10% | 954 | 3.09K | Oct 30, 2024 |